“…Associated with chromosome 5 and/or 7 anomalies in 4 AML (Fugazza et al, 1997;PicosCardenas et al, 2002;Preiss et al, 2006;Duhoux et al, 2011) and with t(9;22)(q34;q11) in 1 CML (Phan et al 2006) and 2 ALL cases (Uckun etal 1998;Schmidt-Hieber et al 2010). Very complex karyotypes (≥5 abnormalities) were observed in 15 patients (Bastard et al,1991;Fugazza et al, 1997;Rajkumar et al, 1999;Bang et al, 2006;Phan et al, 2006;Preiss et al, 2006;Nordgren et al, 2000;Schmidt-Hieber et al, 2010;Vekemans et al, 2010;Duhoux et al, 2011;Subramaniyam et al, 2011;Sawyer et al, 2014;Safavi et al 2015) while there seems to be an over-representation of complex anomalies in AML, ALL and B-cell hematological neoplasms.…”